Network Pharmacology-Assisted Multi-Omics Analysis of Gut Microbiota-Host Metabolic Remodeling and Hepatic HPD/GSTM3-Associated Redox Responses Following Shanqijing Treatment in STZ-Induced Diabetic Mice.
7 affiliations
- 1Institute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
- 2School of Pharmacy, Harbin University of Commerce, Harbin 150076, China.
- 3School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
- 4School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, China.
- 5The Third Clinical College, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
- 6Shanxi Administration for Market Regulation, Taiyuan 030012, China.
- 7Shanxi Laboratory for the Development of New TCM Products, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Abstract
Background/Objectives: Shanqijing (SQJ) is a multibotanical aqueous extract prepared from an equal-ratio blend of Astragali Radix, Dioscoreae Rhizoma, Corni Fructus, Polygonati Rhizoma, and Polygonati Odorati Rhizoma. This study investigated the pharmacological effects and systems-level response pattern of SQJ in streptozotocin-induced diabetic mice. Methods: The study integrated chemical profiling, multi-omics analyses, and network pharmacology-assisted analysis with targeted assessment of hepatic HPD/GSTM3 expression and oxidative stress. Results: UHPLC-Orbitrap MS/MS putatively annotated 250 constituents in SQJ. SQJ lowered fasting blood glucose, improved oral glucose tolerance and serum insulin, reduced inflammatory and hepatic injury indices, and was accompanied by qualitatively improved pancreatic, hepatic, and intestinal histological appearances in representative blinded assessments. Serum metabolomics revealed the partial normalization of aromatic amino acid metabolism, lysophospholipid remodeling, α-linolenic acid metabolism, and polyunsaturated fatty acid-derived oxylipins. SQJ also reshaped the cecal microbiota and partially restored colonic short-chain fatty acids, although the SCFA response was non-monotonic across doses. Integrated metabolite-gene mapping and network pharmacology-assisted compound-target analysis prioritized metabolic and redox-associated host response nodes. Targeted hepatic assessment showed SQJ-responsive normalization of HPD and GSTM3 expression, lower MDA, and recovery of SOD activity and GSH. Conclusions: Collectively, SQJ treatment improved glucose-related and tissue-injury endpoints and was accompanied by coordinated intestinal microbial, circulating metabolic, and hepatic redox responses. These findings are consistent with a distributed systems-level response pattern rather than a single linear gut-to-liver mechanism and provide a basis for further evaluation of SQJ in diabetic metabolic disturbance. The causal contribution of microbial metabolites and the functional requirement for HPD/GSTM3 remain to be established.
Related
- Nervonic acid ameliorates high-fat diet-induced obesity and is associated with gut microbiota, fecal metabolic remodeling, and short-chain fatty acid profiles
- Gut microbiota disturbance disrupts osteonal organization and mechanical competence during postnatal cortical bone maturation in rabbits with local metabolic and transcriptional remodeling.
- The constitutive androstane receptor protects against metabolic dysfunction-associated steatotic liver disease through sex specific interactions with the gut microbiota
- Successive and Isoform-Specific Remodeling of Hepatic Drug-Metabolizing Enzymes during Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis Progression
- Targeting Gut Microbiota, Inflammation, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: Therapeutic Strategies and the Emerging Role of Time-Restricted Feeding
BibTeX
@article{kong2026network,
title = {{Network Pharmacology-Assisted Multi-Omics Analysis of Gut Microbiota-Host Metabolic Remodeling and Hepatic HPD/GSTM3-Associated Redox Responses Following Shanqijing Treatment in STZ-Induced Diabetic Mice.}},
author = {Xiangpeng Kong and Haiqin Ren and Jiani He and Ke Pei and Hui Zhang and Haixin Liu and Zhuqing Song and Yujia Liu and Zhuoyang Wei and Yiwei Chen and Kaifan Yang and Wenhui Deng and Yuxia Guo and Huifeng Li and Yuanbiao Qiao and Miaorong Pei},
journal = {Pharmaceuticals (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/ph19101602},
url = {https://europepmc.org/article/MED/42943299},
note = {CC BY},
}
RIS
TY - JOUR
TI - Network Pharmacology-Assisted Multi-Omics Analysis of Gut Microbiota-Host Metabolic Remodeling and Hepatic HPD/GSTM3-Associated Redox Responses Following Shanqijing Treatment in STZ-Induced Diabetic Mice.
AU - Xiangpeng Kong
AU - Haiqin Ren
AU - Jiani He
AU - Ke Pei
AU - Hui Zhang
AU - Haixin Liu
AU - Zhuqing Song
AU - Yujia Liu
AU - Zhuoyang Wei
AU - Yiwei Chen
AU - Kaifan Yang
AU - Wenhui Deng
AU - Yuxia Guo
AU - Huifeng Li
AU - Yuanbiao Qiao
AU - Miaorong Pei
PY - 2026
DA - 2026/10/09
JO - Pharmaceuticals (Basel, Switzerland)
DO - 10.3390/ph19101602
UR - https://europepmc.org/article/MED/42943299
AB - Background/Objectives: Shanqijing (SQJ) is a multibotanical aqueous extract prepared from an equal-ratio blend of Astragali Radix, Dioscoreae Rhizoma, Corni Fructus, Polygonati Rhizoma, and Polygonati Odorati Rhizoma. This study investigated the pharmacological effects and systems-level response pattern of SQJ in streptozotocin-induced diabetic mice. Methods: The study integrated chemical profiling, multi-omics analyses, and network pharmacology-assisted analysis with targeted assessment of hepatic HPD/GSTM3 expression and oxidative stress. Results: UHPLC-Orbitrap MS/MS putatively annotated 250 constituents in SQJ. SQJ lowered fasting blood glucose, improved oral glucose tolerance and serum insulin, reduced inflammatory and hepatic injury indices, and was accompanied by qualitatively improved pancreatic, hepatic, and intestinal histological appearances in representative blinded assessments. Serum metabolomics revealed the partial normalization of aromatic amino acid metabolism, lysophospholipid remodeling, α-linolenic acid metabolism, and polyunsaturated fatty acid-derived oxylipins. SQJ also reshaped the cecal microbiota and partially restored colonic short-chain fatty acids, although the SCFA response was non-monotonic across doses. Integrated metabolite-gene mapping and network pharmacology-assisted compound-target analysis prioritized metabolic and redox-associated host response nodes. Targeted hepatic assessment showed SQJ-responsive normalization of HPD and GSTM3 expression, lower MDA, and recovery of SOD activity and GSH. Conclusions: Collectively, SQJ treatment improved glucose-related and tissue-injury endpoints and was accompanied by coordinated intestinal microbial, circulating metabolic, and hepatic redox responses. These findings are consistent with a distributed systems-level response pattern rather than a single linear gut-to-liver mechanism and provide a basis for further evaluation of SQJ in diabetic metabolic disturbance. The causal contribution of microbial metabolites and the functional requirement for HPD/GSTM3 remain to be established.
SN - 1424-8247
ER -